Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEO-RIT - Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)

NCT01257360 is registered in ClinicalTrials.gov with WiSP Wissenschaftlicher Service Pharma GmbH as lead sponsor.

NCT NCT01257360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01257360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEO-RIT - Panitumumab in Combination With Radiotherapy in Patients With Locally Advanced RAS Wildtype Rectal Cancer (Clinical Stages II and III)
Lead sponsor
WiSP Wissenschaftlicher Service Pharma GmbH
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2010
Completion date
July 31, 2016
Enrollment
59 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rectal cancer